title: [Renal carcinoma in childhood].
abstract: Our data on treatment of renal carcinoma in 12 children (1996-2006) are presented. Nephrectomy and lymph node dissection was carried out in all patients; adjuvant chemotherapy (doxorubicin, interferon alpha2b (IBF alpha2b/Intron A) with concomitant whole body hyperthermia (systemic thermobiochemotherapy--7. Overall 10-year survival in all patients was 91% (median 42.3 months). Survival rate in cases of advanced renal carcinoma who received postoperative thermobiochemotherapy was 86% (median 54.8 months). Our results suggest that thermobiochemotherapy be indicated in children with advanced renal carcinoma.
authors.forename: R S
authors.initials: RS
authors.lastname: Ismail-zade
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000175:diagnosis* / Q000628:therapy*; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002291:Carcinoma, Papillary / Q000175:diagnosis* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002648:Child; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D053208:Kaplan-Meier Estimate; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D009392:Nephrectomy; D011994:Recombinant Proteins; D002094:Republic of Belarus; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins